337
Views
27
CrossRef citations to date
0
Altmetric
Original Research

Mapping the cancer-specific QLQ-C30 onto the generic EQ-5D-5L and SF-6D in colorectal cancer patients

, , , , &
Pages 89-96 | Received 07 Jan 2018, Accepted 24 Aug 2018, Published online: 03 Sep 2018

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (3)

ZhiKui He, WenJie Liang, WenJia Xu, WenXiu Huang, XiaoMin Wang, KaiYong Huang & Li Yang. (2022) Mapping the FACT-G to EQ-5D-3L utility index in cancer with the Chinese values set. Expert Review of Pharmacoeconomics & Outcomes Research 22:7, pages 1103-1116.
Read now
Hosein Ameri, Hossein Safari & Thomas Poder. (2021) Exploring the consistency of the SF-6Dv2 in a breast cancer population. Expert Review of Pharmacoeconomics & Outcomes Research 21:5, pages 1017-1024.
Read now
Binh Thang Tran, Nhu Hiep Pham, Thanh Xuan Nguyen, Kui Son Choi, Dae Kyung Sohn, Sun-Young Kim, Jae Kyung Suh, Thuy Duyen Nguyen, Van Sang Phan, Dinh Trung Tran, The Thanh Nguyen, Thi Thanh Binh Nguyen, Minh Tu Nguyen & Jin-Kyoung Oh. (2020) Measurement of Health-Related Quality of Life Among Colorectal Cancer Patients Using the Vietnamese Value Set of the EQ-5D-5L. Patient Preference and Adherence 14, pages 2427-2437.
Read now

Articles from other publishers (24)

Qing Yang, Long Lin Jiang, Yin Feng Li & Deyu Huang. (2023) Prediction of the SF-6D utility score from Lung cancer FACT-L: a mapping study in China. Health and Quality of Life Outcomes 21:1.
Crossref
Deyu Huang, Dingfen Zeng, Yuan Tang, Longlin Jiang & Qing Yang. (2023) Mapping the EORTC QLQ-C30 and QLQ H&N35 to the EQ-5D-5L and SF-6D for papillary thyroid carcinoma. Quality of Life Research.
Crossref
Qing Yang, Deyu Huang, Longlin Jiang, Yuan Tang & Dingfen Zeng. (2023) Obtaining SF-6D utilities from FACT-H&N in thyroid carcinoma patients: development and results from a mapping study. Frontiers in Endocrinology 14.
Crossref
Ana Sofia Oliveira Gonçalves, Sophia Werdin, Tobias Kurth & Dimitra Panteli. (2023) Mapping Studies to Estimate Health-State Utilities From Nonpreference-Based Outcome Measures: A Systematic Review on How Repeated Measurements are Taken Into Account. Value in Health 26:4, pages 589-597.
Crossref
Deyu Huang, Jialing Peng, Na Chen, Qing Yang & Longlin Jiang. (2023) Mapping study of papillary thyroid carcinoma in China: Predicting EQ-5D-5L utility values from FACT-H&N. Frontiers in Public Health 11.
Crossref
Maryam Shirvani Shiri, Hassan Karami, Hosein Ameri, Ali Akbari Sari, Maryam Tatari, Sara Emamgholipour & Somayeh Afshari. (2023) The influencing factors of health–related quality of life of the general population of Iran during the COVID-19 Pandemic. Frontiers in Medicine 10.
Crossref
Yasuhiro Hagiwara, Takeru Shiroiwa, Naruto Taira, Takuya Kawahara, Keiko Konomura, Shinichi Noto, Takashi Fukuda & Kojiro Shimozuma. (2023) Gradient Boosted Tree Approaches for Mapping European Organization for Research and Treatment of Cancer Quality of Life Questionnaire Core 30 Onto 5-Level Version of EQ-5D Index for Patients With Cancer. Value in Health 26:2, pages 269-279.
Crossref
Shiwei Qin & Zili Dai. (2023) Interpolation Technique for the Underwater DEM Generated by an Unmanned Surface Vessel. Computer Modeling in Engineering & Sciences 136:3, pages 3157-3172.
Crossref
Richard Huan Xu, Dong Dong, Nan Luo, Eliza Lai-Yi Wong, Renchi Yang, Junshuai Liu, Huiqin Yuan & Shuyang Zhang. (2021) Mapping the Haem-A-QoL to the EQ-5D-5L in patients with hemophilia. Quality of Life Research 31:5, pages 1533-1544.
Crossref
Dulakshi Santhusitha Kumari Karunasingha. (2022) Root mean square error or mean absolute error? Use their ratio as well. Information Sciences 585, pages 609-629.
Crossref
Aurelie Meunier, Alexandra Soare, Helene Chevrou-Severac, Karl-Johan Myren, Tatsunori Murata & Louise Longworth. (2021) Indirect and Direct Mapping of the Cancer-Specific EORTC QLQ-C30 onto EQ-5D-5L Utility Scores. Applied Health Economics and Health Policy 20:1, pages 119-131.
Crossref
Maral Seyed Ahadi, Niusha Vahidpour, Mansoureh Togha, Rajabali Daroudi, Fatemeh Nadjafi-Semnani, Zahra Mohammadshirazi, Ali Akbari-sari & Zeinab Ghorbani. (2021) Assessment of Utility in Migraine: Mapping the Migraine-Specific Questionnaire to the EQ-5D-5L. Value in Health Regional Issues 25, pages 57-63.
Crossref
Mahmood Yousefi, Azin Nahvijou, Ali Akbari Sari & Hosein Ameri. (2021) Mapping QLQ-C30 Onto EQ-5D-5L and SF-6D-V2 in Patients With Colorectal and Breast Cancer From a Developing Country. Value in Health Regional Issues 24, pages 57-66.
Crossref
Forouzan Zare, Hosein Ameri, Farzan Madadizadeh & Mohammad Reza Aghaei. (2021) Validity and reliability of the EQ-5D-3L (a generic preference-based instrument used for calculating quality-adjusted life -years) for patients with type 2 diabetes in Iran. Diabetes & Metabolic Syndrome: Clinical Research & Reviews 15:1, pages 319-324.
Crossref
Azin Nahvijou, Hossein Safari, Mahmood Yousefi, Marziyeh Rajabi, Morteza Arab-Zozani & Hosein Ameri. (2020) Mapping the cancer-specific FACT-B onto the generic SF-6Dv2. Breast Cancer 28:1, pages 130-136.
Crossref
Yasuhiro Hagiwara, Takeru Shiroiwa, Naruto Taira, Takuya Kawahara, Keiko Konomura, Shinichi Noto, Takashi Fukuda & Kojiro Shimozuma. (2020) Mapping EORTC QLQ-C30 and FACT-G onto EQ-5D-5L index for patients with cancer. Health and Quality of Life Outcomes 18:1.
Crossref
Mira D. Franken, Anne de Hond, Koen Degeling, Cornelis J. A. Punt, Miriam Koopman, Carin A. Uyl-de Groot, Matthijs M. Versteegh & Martijn G. H. van Oijen. (2020) Evaluation of the performance of algorithms mapping EORTC QLQ-C30 onto the EQ-5D index in a metastatic colorectal cancer cost-effectiveness model. Health and Quality of Life Outcomes 18:1.
Crossref
Morteza Arab-Zozani, Fatemah Hashemi, Hossein Safari, Mahmood Yousefi & Hosein Ameri. (2020) Health-Related Quality of Life and its Associated Factors in COVID-19 Patients. Osong Public Health and Research Perspectives 11:5, pages 296-302.
Crossref
Azin Nahvijou, Hossein Safari & Hosein Ameri. (2020) Comparing the performance of the EQ-5D-5L with two versions of the SF-6Dv2 in patients with breast cancer. Health Services and Outcomes Research Methodology 20:2-3, pages 183-194.
Crossref
Amirali Moradpour, Mohamad Hadian & Mahmoud Tavakkoli. (2020) Economic evaluation of End Stage Renal Disease treatments in Iran. Clinical Epidemiology and Global Health 8:1, pages 199-204.
Crossref
Hosein Ameri, Mahmood Yousefi, Mehdi Yaseri, Azin Nahvijou, Mohammad Arab & Ali Akbari Sari. (2019) Mapping EORTC-QLQ-C30 and QLQ-CR29 onto EQ-5D-5L in Colorectal Cancer Patients. Journal of Gastrointestinal Cancer 51:1, pages 196-203.
Crossref
Forouzan Zare, Hosein Ameri, Farzan Madadizadeh & Mohammad Reza Aghaei. (2020) Health-related quality of life and its associated factors in patients with type 2 diabetes mellitus. SAGE Open Medicine 8, pages 205031212096531.
Crossref
Mahmood Yousefi, Hossein Safari, Ali Akbari Sari, Behzad Raei & Hosein Ameri. (2019) Assessing the performance of direct and indirect utility eliciting methods in patients with colorectal cancer: EQ-5D-5L versus C-TTO. Health Services and Outcomes Research Methodology 19:4, pages 259-270.
Crossref
Clara Mukuria, Donna Rowen, Sue Harnan, Andrew Rawdin, Ruth Wong, Roberta Ara & John Brazier. (2019) An Updated Systematic Review of Studies Mapping (or Cross-Walking) Measures of Health-Related Quality of Life to Generic Preference-Based Measures to Generate Utility Values. Applied Health Economics and Health Policy 17:3, pages 295-313.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.